Literature DB >> 22651852

Functional and patient-reported outcomes in symptomatic lumbar spinal stenosis following percutaneous decompression.

Nagy Mekhail1, Shrif Costandi, Benjamin Abraham, Samuel Wadie Samuel.   

Abstract

BACKGROUND: Neurogenic claudication due to symptomatic lumbar spinal stenosis (LSS) is a painful condition causing significant functional disability. While the cause of LSS is multifactorial, thickened ligamentum flavum (LF) accounts for up to 85% of spinal canal narrowing. mild percutaneous lumbar decompression allows debulking of the hypertrophic LF while avoiding the morbidities frequently associated with more invasive surgical procedures.
METHODS: In this prospective case series study, consecutive LSS patients presenting with neurogenic claudication were treated with percutaneous lumbar decompression. Efficacy was evaluated using the Pain Disability Index (PDI) and Roland-Morris Disability Questionnaire. Pre- and postprocedure Standing Time, Walking Distance, and Visual Analog Score (VAS) were also monitored. Significant device- or procedure-related adverse events were reported.
RESULTS: The mild procedure was successfully performed on forty patients. At twelve months, both PDI and Roland-Morris showed significant improvement of 22.6 points (ANOVA, P<0.0001) and 7.7 points (ANOVA, P<0.0001), respectively. Walking Distance, Standing Time, and VAS improvements were also statistically significant, increasing from 246 to 3,956 feet (ANOVA, P<0.0001), 8 to 56 minutes (ANOVA, P<0.0001), and 7.1 to 3.6 points (ANOVA, P<0.0001), respectively. Tukey HSD test found improvement in all 5-outcome measures to be significant from baseline at each follow-up interval. No significant device- or procedure-related adverse events were reported.
CONCLUSION: This study demonstrated significant functional improvement as well as decreased disability secondary to neurogenic claudication after mild procedure. Safety, cost-effectiveness, and quality-of-life outcomes are best compared with comprehensive medical management in a randomized controlled fashion and, where ethical, to open lumbar decompression surgery.
© 2012 The Authors. Pain Practice © 2012 World Institute of Pain.

Entities:  

Mesh:

Year:  2012        PMID: 22651852     DOI: 10.1111/j.1533-2500.2012.00565.x

Source DB:  PubMed          Journal:  Pain Pract        ISSN: 1530-7085            Impact factor:   3.183


  8 in total

1.  The 2-year cost-effectiveness of 3 options to treat lumbar spinal stenosis patients.

Authors:  Belinda L Udeh; Shrif Costandi; Jarrod E Dalton; Raktim Ghosh; Hani Yousef; Nagy Mekhail
Journal:  Pain Pract       Date:  2014-01-03       Impact factor: 3.183

Review 2.  The clinical course of pain and disability following surgery for spinal stenosis: a systematic review and meta-analysis of cohort studies.

Authors:  Carolina G Fritsch; Manuela L Ferreira; Christopher G Maher; Robert D Herbert; Rafael Z Pinto; Bart Koes; Paulo H Ferreira
Journal:  Eur Spine J       Date:  2016-07-21       Impact factor: 3.134

3.  The durability of minimally invasive lumbar decompression procedure in patients with symptomatic lumbar spinal stenosis: Long-term follow-up.

Authors:  Nagy Mekhail; Shrif Costandi; George Nageeb; Catherine Ekladios; Ogena Saied
Journal:  Pain Pract       Date:  2021-05-13       Impact factor: 3.079

4.  Outcome of modified interlaminar decompression: A conservative decompressive surgery for lumbar spine stenosis.

Authors:  Farooq Azam; Seema Sharafat; Zahid Khan; Mumtaz Ali
Journal:  Pak J Med Sci       Date:  2020 May-Jun       Impact factor: 1.088

5.  The Impact of Age on the Outcomes of Minimally Invasive Lumbar Decompression for Lumbar Spinal Stenosis.

Authors:  Nagy A Mekhail; Shrif J Costandi; Sherif Armanyous; Ricardo Vallejo; Lawrence R Poree; Lora L Brown; Stanley Golovac; Timothy R Deer
Journal:  Med Devices (Auckl)       Date:  2020-06-04

6.  The MOTION Study: A Randomized Controlled Trial with Objective Real-World Outcomes for Lumbar Spinal Stenosis Patients Treated with the mild® Procedure: One-Year Results.

Authors:  Timothy R Deer; Shrif J Costandi; Edward Washabaugh; Timothy B Chafin; Sayed E Wahezi; Navdeep Jassal; Dawood Sayed
Journal:  Pain Med       Date:  2022-04-08       Impact factor: 3.750

7.  Ablation of porcine ligamentum flavum with Ho:YAG, q-switched Ho:YAG, and quadrupled Nd:YAG lasers.

Authors:  Matt R Johnson; Patrick J Codd; Westin M Hill; Tara Boettcher
Journal:  Lasers Surg Med       Date:  2015-09-28       Impact factor: 4.025

8.  Objective Real-World Outcomes of Patients Suffering from Painful Neurogenic Claudication Treated with the mild® Procedure: Interim 6-Month Report of a Randomized Controlled Trial.

Authors:  Timothy Deer; Christopher Kim; Sayed Emal Wahezi; Huaguang Qu; Dawood Sayed
Journal:  J Pain Res       Date:  2021-06-10       Impact factor: 3.133

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.